1063 related articles for article (PubMed ID: 25544499)
1. Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection.
Wong MT; Chen SS
Cell Mol Immunol; 2016 Jan; 13(1):11-35. PubMed ID: 25544499
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.
Yamashita T; Honda M; Kaneko S
J Gastroenterol Hepatol; 2011 Jun; 26(6):960-4. PubMed ID: 21443660
[TBL] [Abstract][Full Text] [Related]
3. Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
Qi H; Chu V; Wu NC; Chen Z; Truong S; Brar G; Su SY; Du Y; Arumugaswami V; Olson CA; Chen SH; Lin CY; Wu TT; Sun R
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2018-2023. PubMed ID: 28159892
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
Yang DR; Zhu HZ
World J Gastroenterol; 2015 Apr; 21(13):3786-800. PubMed ID: 25852264
[TBL] [Abstract][Full Text] [Related]
5. Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity.
Piconese S; Cammarata I; Barnaba V
J Autoimmun; 2018 Dec; 95():58-68. PubMed ID: 30509387
[TBL] [Abstract][Full Text] [Related]
6. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
7. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.
Thomas E; Gonzalez VD; Li Q; Modi AA; Chen W; Noureddin M; Rotman Y; Liang TJ
Gastroenterology; 2012 Apr; 142(4):978-88. PubMed ID: 22248663
[TBL] [Abstract][Full Text] [Related]
8. Innate immunity against hepatitis C virus.
Xu Y; Zhong J
Curr Opin Immunol; 2016 Oct; 42():98-104. PubMed ID: 27366996
[TBL] [Abstract][Full Text] [Related]
9. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
10. Innate immunity and HCV.
Heim MH
J Hepatol; 2013 Mar; 58(3):564-74. PubMed ID: 23063572
[TBL] [Abstract][Full Text] [Related]
11. Innate and adaptive immune responses in HCV infections.
Heim MH; Thimme R
J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus: Enslavement of host factors.
Sharma G; Raheja H; Das S
IUBMB Life; 2018 Jan; 70(1):41-49. PubMed ID: 29281185
[TBL] [Abstract][Full Text] [Related]
13. The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.
Bruening J; Weigel B; Gerold G
J Immunol Res; 2017; 2017():7232361. PubMed ID: 28255563
[TBL] [Abstract][Full Text] [Related]
14. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity.
Ding Q; Cao X; Lu J; Huang B; Liu YJ; Kato N; Shu HB; Zhong J
J Hepatol; 2013 Jul; 59(1):52-8. PubMed ID: 23542348
[TBL] [Abstract][Full Text] [Related]
16. Between Scylla and Charybdis: the role of the human immune system in the pathogenesis of hepatitis C.
Spengler U; Nischalke HD; Nattermann J; Strassburg CP
World J Gastroenterol; 2013 Nov; 19(44):7852-66. PubMed ID: 24307779
[TBL] [Abstract][Full Text] [Related]
17. Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.
Ishibashi M; Yamaguchi H; Hirotani Y; Sakurada A; Endo T; Sugitani M; Takayama T; Makishima M; Esumi M
Arch Virol; 2018 Apr; 163(4):855-865. PubMed ID: 29248968
[TBL] [Abstract][Full Text] [Related]
18. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
Dharel N; Kato N; Muroyama R; Taniguchi H; Otsuka M; Wang Y; Jazag A; Shao RX; Chang JH; Adler MK; Kawabe T; Omata M
Hepatology; 2008 Apr; 47(4):1136-49. PubMed ID: 18220274
[TBL] [Abstract][Full Text] [Related]
19. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
[TBL] [Abstract][Full Text] [Related]
20. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
